This is a request for continuation of NCI recognition of comprehensive status and of Cancer Center Support Grant funding for the Norris Cotton Cancer Center (NCCC) at Dartmouth-Hitchcock Medical Center (DHMC). NCCC is a matrix-type cancer center, organized as an interdepartmental component of DHMC, with overall responsibility for cancer research, cancer care, and educational and service activities in cancer. Our request is for five years (Years 26-30) of funding for the core infrastructure that supports cancer research at NCCC. The 131 scientists of the NCCC are organized into six Research Programs: Cancer Control; Cancer Epidemiology and Chemoprevention; Cancer Mechanisms; Molecular Therapeutics; Immunology and Cancer Immunotherapy; and Radiobiology and Bioengineering. Each of these Research Programs integrates peer-reviewed funded cancer researchers from a variety of basic science and clinical or population science disciplines. The research efforts of these Programs receive support through NCCC Shared Resources in Behavioral Science, Bioinformatics, Flow Cytometry/Fluorescence Imaging, Glassware Washing, Hybridoma Library/Monoclonal Antibody Production, Immune Monitoring Laboratory, Irradiation, Microarray, Molecular Biology and Proteomics, Transgenic Mouse, Biostatistics, Clinical and Molecular Pharmacology, Research Pathology Services, and Clinical Research Office. The NCCC provides developmental funds to support innovative, collaborative pilot projects; new shared resources; and the initial research efforts of new investigators. We request support for these developmental efforts and for leadership, administrative, shared resource and planning activities that are crucial to the maintenance of a coordinated and interactive program in cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023108-27
Application #
6917790
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ciolino, Henry P
Project Start
1997-08-04
Project End
2008-11-30
Budget Start
2004-12-01
Budget End
2005-11-30
Support Year
27
Fiscal Year
2005
Total Cost
$2,918,751
Indirect Cost
Name
Dartmouth College
Department
Pediatrics
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Allaway, Robert J; Wood, Matthew D; Downey, Sondra L et al. (2018) Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells. Oncotarget 9:15860-15875
Soneji, Samir; Yang, JaeWon; Knutzen, Kristin E et al. (2018) Online Tobacco Marketing and Subsequent Tobacco Use. Pediatrics 141:
Rosenthal, Meredith B; Colla, Carrie H; Morden, Nancy E et al. (2018) Overuse and insurance plan type in a privately insured population. Am J Manag Care 24:140-146
El-Jawahri, Areej; Fishman, Sarah R; Vanderklish, Julie et al. (2018) Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation. Cancer 124:2438-2446
Fricano-Kugler, Catherine J; Getz, Stephanie A; Williams, Michael R et al. (2018) Nuclear Excluded Autism-Associated Phosphatase and Tensin Homolog Mutations Dysregulate Neuronal Growth. Biol Psychiatry 84:265-277
Everson, Todd M; Punshon, Tracy; Jackson, Brian P et al. (2018) Cadmium-Associated Differential Methylation throughout the Placental Genome: Epigenome-Wide Association Study of Two U.S. Birth Cohorts. Environ Health Perspect 126:017010
Yang, Wei; Schwartz, Gary N; Marotti, Jonathan D et al. (2018) Estrogen receptor alpha drives mTORC1 inhibitor-induced feedback activation of PI3K/AKT in ER+ breast cancer. Oncotarget 9:8810-8822
Andrew, Angeline S; Chen, Celia Y; Caller, Tracie A et al. (2018) Toenail mercury Levels are associated with amyotrophic lateral sclerosis risk. Muscle Nerve :
Gacerez, Albert T; Sentman, Charles L (2018) T-bet promotes potent antitumor activity of CD4+ CAR T cells. Cancer Gene Ther 25:117-128
Lyons, Kathleen Doyle; Newman, Robin; Adachi-Mejia, Anna M et al. (2018) Content Analysis of a Participant-Directed Intervention to Optimize Activity Engagement of Older Adult Cancer Survivors. OTJR (Thorofare N J) 38:38-45

Showing the most recent 10 out of 1911 publications